The interplay between CD4 cell count, viral load suppression and duration of antiretroviral therapy on mortality in a resource‐limited setting

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Tropical medicine & international health

• Publication date

  2013-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/tmi.12079PMID 23419157PMCID PMC3625450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa: a systematic review and meta-analysis

  2013cited by this paper
• COHORT PROFILE Cohort Profile : The Themba Lethu Clinical Cohort , Johannesburg , South Africa

  2013cited by this paper
• CD4 Cell Count and the Risk of AIDS or Death in HIV-Infected Adults on Combination Antiretroviral Therapy with a Suppressed Viral Load: A Longitudinal Cohort Study from COHERE

  2012cited by this paper
• Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review

  2011cited by this paper
• Ongoing changes in HIV RNA levels during untreated HIV infection: implications for CD4 cell count depletion

  2010influential reference
• The importance of clinic attendance in the first six months on antiretroviral treatment: a retrospective analysis at a large public sector HIV clinic in South Africa

  2010cited by this paper
• Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007

  2010cited by this paper
• Using vital registration data to update mortality among patients lost to follow‐up from ART programmes: evidence from the Themba Lethu Clinic, South Africa

  2010cited by this paper
• Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.

  2010influential reference
• Long-Term Patterns in CD4 Response Are Determined by an Interaction Between Baseline CD4 Cell Count, Viral Load, and Time: The Asia Pacific HIV Observational Database (APHOD)

  2009cited by this paper
• Mortality of HIV-Infected Patients Starting Antiretroviral Therapy in Sub-Saharan Africa: Comparison with HIV-Unrelated Mortality

  2009influential reference
• Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa

  2009influential reference
• Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring

  2009cited by this paper
• Association between HIV-1 RNA level and CD4 cell count among untreated HIV-infected individuals.

  2009cited by this paper
• Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements

  2009cited by this paper
• Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland Compared

  2008influential reference
• Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

  2008influential reference
• Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa

  2007cited by this paper
• Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.

  2006influential reference
• Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi

  2006influential reference
• Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control

  2006cited by this paper
• Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

  2006influential reference
• Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation.

  2006cited by this paper
• Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study

  2006influential reference
• Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

  2006influential reference
• Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design

  2005influential reference
• Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.

  2005cited by this paper
• Mortality and causes of death in South Africa, 1997-2003: findings from death notifications.

  2005cited by this paper
• Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.

  2004cited by this paper
• A modified poisson regression approach to prospective studies with binary data.

  2004cited by this paper
• Mortality and progression to AIDS after starting highly active antiretroviral therapy

  2003cited by this paper
• Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

  2003cited by this paper
• Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance.

  2003cited by this paper
• Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category

  2003cited by this paper
• Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies.

  2003cited by this paper
• Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

  2002cited by this paper
• Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study.

  2001cited by this paper
• Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults

  2001cited by this paper
• Longitudinal Patterns of HIV Type 1 RNA among Individuals with Late Disease Progression

  2001cited by this paper
• Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection.

  2000cited by this paper
• AIDS across Europe, 1994-98: the EuroSIDA study.

  2000cited by this paper
• Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study.

  1999cited by this paper
• Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort study

  1999cited by this paper
• Risk of new AIDS diseases in people on triple therapy.

  1999cited by this paper
• Vitamin C intake and susceptibility to pneumonia.

  1997cited by this paper
• [Modern epidemiology].

  1971cited by this paper

• Multifactorial determinants of lost to follow-up in antiretroviral therapy: evidence from a case–control study in Mexico

  2026cites this paper
• Comparative Analysis of Parametric Survival Models in HIV Patient Data

  2025cites this paper
• Evaluating the impact of the COVID-19 pandemic on viral load and CD4 monitoring for people living with HIV on ART in rural Lesotho

  2025cites this paper
• Experiences of people living with HIV/AIDS in selected hospitals in Imo state, Nigeria, regarding the usability and satisfaction of reminders using M-health features: a qualitative study

  2025cites this paper
• Predictors for viral load suppression among HIV positive adults under ART treatment in University of Gondar Comprehensive Specialized Hospital: retrospective cohort study

  2024cites this paper
• Estimating the mortality risk correcting for high loss to follow-up among female sex workers with HIV in Durban, South Africa, 2018-2021.

  2024cites this paper
• Systematic review on cumulative HIV viraemia among people living with HIV receiving antiretroviral treatment and its association with mortality and morbidity

  2023cites this paper
• Retention in Care and Virological Failure among Adult HIV-Positive Patients on First-Line Antiretroviral Treatment in Maputo, Mozambique

  2023cites this paper
• Incidence of Pneumonia and Predictors Among Human Immunodeficiency Virus Infected Children at Public Health Institutions in the Northwest Part of Ethiopia: Multicenter Retrospective Follow-Up Study

  2022cites this paper
• Spatiotemporal Variation and Predictors of Unsuppressed Viral Load among HIV-Positive Men and Women in Rural and Peri-Urban KwaZulu-Natal, South Africa

  2022cites this paper
• Higher Risk of Mortality and Virologic Failure in HIV-Infected Patients With High Viral Load at Antiretroviral Therapy Initiation: An Observational Cohort Study in Chongqing, China

  2022cites this paper
• Incidence of cardiometabolic diseases in a Lesotho HIV cohort: Evidence for policy decision-making

  2021cites this paper
• The effect of longitudinal body weight and CD4 cell progression for the survival of HIV/AIDS patients

  2021cites this paper
• Baseline Viral Load Predicts Antiretroviral Therapy Outcomes Among HIV-Infected Patients: An Observational Cohort Study

  2021cites this paper
• Immunological Treatment Failure Among Adult Patients Receiving Highly Active Antiretroviral Therapy in East Africa: A Systematic Review and Meta-Analysis

  2021cites this paper
• Cognitive ageing is premature among a community sample of optimally treated people living with HIV

  2020cites this paper
• Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study

  2020cites this paper
• Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy

  2020cites this paper
• Predicting TB treatment outcomes using baseline risk and treatment response markers: developing the PredictTB early treatment completion criteria

  2020cites this paper
• Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study

  2020cites this paper
• Predictors of mortality in adult people living with HIV on antiretroviral ther-

  2020cites this paper
• A superiority of viral load over CD4 cell count when predicting mortality in HIV patients on therapy

  2019cites this paper
• A comparison of the time homogeneous and time non-homogeneous markov models for monitoring HIV/AIDS disease progression: Results from patients on ART.

  2019cites this paper
• Diagnóstico al alta y causas de mortalidad de pacientes VIH+ ingresados en un hospital de tercer nivel

  2019cites this paper
• Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South Africa

  2019cites this paper
• Predictors of mortality in adult people living with HIV on antiretroviral therapy in Nepal: A retrospective cohort study, 2004-2013

  2019cites this paper
• Survival of adults with HIV-1 infection or Type 2 diabetes in the South African private sector

  2019cites this paper
• “My future is bright…I won't die with the cause of AIDS”: ten‐year patient ART outcomes and experiences in South Africa

  2018cites this paper
• Rethinking retention: Mapping interactions between multiple factors that influence long-term engagement in HIV care

  2018cites this paper
• Nutrition Services, Viral Suppression, CD4, and Retention in Ryan White Program Participants

  2017cites this paper
• The right combination – treatment outcomes among HIV-positive patients initiating first-line fixed-dose antiretroviral therapy in a public sector HIV clinic in Johannesburg, South Africa

  2017cites this paper
• Evaluating the utility of provider-recorded clinical status in the medical records of HIV-positive adults in a limited-resource setting

  2017cites this paper
• Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial

  2017cites this paper
• Marked sex differences in all-cause mortality on antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysis

  2016influential citation
• Morbidity and Mortality According to Latest CD4+ Cell Count among HIV Positive Individuals in South Africa Who Enrolled in Project Phidisa

  2015cites this paper
• Treatment Outcomes in a Decentralized Antiretroviral Therapy Program: A Comparison of Two Levels of Care in North Central Nigeria

  2014cites this paper
• Baseline factors associated with mortality within six months after admission among hospitalized HIV-1 patients in Shenyang, China.

  2014cites this paper